Christmas

Christmas Greetings!

Team Evado wishes you and yours a safe and Happy Christmas.

The Evado office is now closed until January 9th

For support during the holidays, please email support@evado.com

christmas-2016

Report: Australia 60% cheaper than US for clinical trials

With a tax incentive program making clinical trials up to 60% more cost-effective, Australia is a “gateway” to larger studies throughout Asia, says CRO.

According to the report published by Frost & Sullivan, the clinical trials market is expected to reach $615m by 2019, growing at a CAGR of 12%. Additionally, early phase clinical trials have been growing at nearly twice this rate and growth is expected to continue.

Patient registry software market to hit $2.1B — 8 points

The registry market is expected to reach 2.1 billion US by 2023 based on a Transparency Market Research (TMR).

Asia Pacific is expected to experience the fastest growth.

With PatientCrossroads, Quintiles, Global Vision Technologies, Dacima Software and Evado eClinical Solutions leading the market.

http://www.medgadget.com/2016/04/patient-registry-software-market-to-rise-to-us2-1-bn-by-2023-increasing-awareness-regarding-healthcare-to-fuel-demand.html.

‘Medicalized’ smartphones to put health data in hands of patients

The world is on the verge of a fourth industrial revolution, characterized by artificial intelligence, robots, big data, and deep learning and analytics, but medicine is still stuck at the beginning of the third industrial revolution, which has already brought digital capabilities to billions of people worldwide.

http://www.healthdatamanagement.com/news/medicalized-smartphones-to-put-health-data-in-hands-of-patients

Smartphone health data slammed as ‘voodoo machine learning’

The widespread use of smartphones to collect healthcare data has been thrown into doubt by a couple of recent studies.

In some fields — such as the management of chronic diseases and mental health monitoring smartphones have enabled a greater level of patient self-control, and personalised clinical intervention. Success in one area, however, does not imply success in all – especially as smartphone health apps are often rolled out before evidence of their effectiveness has been rigorously analysed.

Smartphone health data slammed as ‘voodoo machine learning’

Release of eClinical version 4.1.0

Evado is pleased to announce the release of eClinical version 4.1, that has successfully integrated Evado eClinical with Evado UniFORM to deliver our new product, Evado Mobile. Evado Mobile enables site coordinators and monitors to collect, review and monitor clinical trial, study or registry data using the Evado mobile app.